Results 181 to 190 of about 10,618 (207)
Some of the next articles are maybe not open access.
4,5-Dihydropyrazolo[3,4-f]quinazolines
Chemistry of Heterocyclic Compounds, 2003AbstractFor Abstract see ChemInform Abstract in Full Text.
N. N. Tonkikh +3 more
openaire +1 more source
Nature, 1964
THE polarographic behaviour of quinazoline displays special features which are not shown by the related compounds quinoxaline, phthalazine and 1,5-naphthyridine.
openaire +1 more source
THE polarographic behaviour of quinazoline displays special features which are not shown by the related compounds quinoxaline, phthalazine and 1,5-naphthyridine.
openaire +1 more source
Quinazolines. Part X. The fragmentation of quinazolines under electron impact
Journal of the Chemical Society B: Physical Organic, 1967Quinazoline, under electron impact, fragments by the consecutive loss of two molecules of HCN to give a benzyne radical ion. Fragmentation of substituted quinazolines also occurs by this pathway as well as by others normally associated with the breakdown of the substituent.
T. J. Batterham +2 more
openaire +1 more source
Quinazoline Yellow SS in cosmetics
Contact Dermatitis, 1976Five cases of allergic contact dermatitis from Quinazoline Yellow SS (D and C Yellow 11) in cosmetics are described, three from a lipstick and two from a rouge stick. Four of them showed marked oedema spreading to the eyelids and down to the neck. Two of them required systemic steroids.
openaire +2 more sources
528. Quinazolines. Part I. Cations of quinazoline
Journal of the Chemical Society (Resumed), 1961Adrien Albert +2 more
openaire +1 more source
1975
Publisher Summary This chapter covers the literature for the period from the latter part of 1994 to the early part of 1998. This period has seen the continued use of pyrimidine drugs—such as AZT and ddC in the treatment of viral diseases and the development of new analogues of these compounds, for example, 3TC (3’-thiocytosine).
openaire +1 more source
Publisher Summary This chapter covers the literature for the period from the latter part of 1994 to the early part of 1998. This period has seen the continued use of pyrimidine drugs—such as AZT and ddC in the treatment of viral diseases and the development of new analogues of these compounds, for example, 3TC (3’-thiocytosine).
openaire +1 more source

